Clinical study of Hezhong prescription on improving the quality of life of patients with cancer anorexia cachexia syndrome
- Conditions
- ??????????
- Registration Number
- ITMCTR2000003985
- Lead Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Volunteer as a subject and sign an informed consent form.
2. The pathology or cytology is clearly diagnosed as malignant tumor, combined with imaging and other examinations to confirm that the staging is between stage III and
In stage IV, there is no restriction on the type of disease or pathological type; aged 20-80 years old;
3. The patient has symptoms of anorexia cachexia syndrome, which meets the diagnostic criteria; visual analog scale for anorexia (VAS) = 40/100mm; Cachexia scores are early and cachexia stage, excluding refractory cachexia;
4. Eastern Cooperative Oncology Group (ECOG) physical status is less than 3; the expected survival time is greater than 4 months;
5. The subject has no serious heart, brain, kidney, hematopoietic system and endocrine system dysfunction (absolutely neutral Granulocyte count (ANC)>1.5*109/L; platelets>100*10^9/L; hemoglobin>=90g/L; total bile
Red pigment<=1.5 ULN; AST or ALT<=2.5 ULN, if it is clearly attributed to liver metastasis
Shift, then <5*upper limit of normal; UPCR<1.0; creatinine clearance rate>50ml/min; urine protein test result is small
Yu 2+); subjects without mental disorders are conscious and able to cooperate with doctors to complete disease-related examinations Check and evaluate;
6. No obvious eating disorder;
7. Patients who have not received chemotherapy treatment should complete chemotherapy 14 days before randomization in this study;
For patients receiving chemotherapy, the chemotherapy regimen should be limited to the standard regimen. During the study period, it is generally not allowed to change the chemotherapy regimen.
Treatment plan.
not be addressed
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EORTC QLQ-C30;Functional evaluation scale for the treatment of anorexia cachexia syndrome;weight;
- Secondary Outcome Measures
Name Time Method PG-SGA Nutritional Assessment;Clinical symptom questionnaire score;Appetite visual analog scale;Serum albumin;